[Skip to Navigation]
Sign In
Correction
July 29, 2020

Errors in Table 2

JAMA Cardiol. 2020;5(9):1071. doi:10.1001/jamacardio.2020.3183

In the Original Investigation titled “Safety and Efficacy of Femoral Access vs Radial Access in ST-Segment Elevation Myocardial Infarction: The SAFARI-STEMI Randomized Clinical Trial,”1 published in the February issue of JAMA Cardiology, data were incorrectly shown for the type of stent and for 2 of the critical time intervals in Table 2. In the “Radial Access” column, the No./total No. (%) was changed to 912/1043 (87.4%) for drug-eluting stents, 123/1043 (11.8%) for bare metal stents, and 8/1043 (0.8%) for both, and the median (interquartile range) critical time interval was changed to 189 (136-300) minutes for “Symptom onset to first balloon inflation/device” and 48 (36-64) minutes for “Arrival at PCI [percutaneous coronary intervention] center to first balloon inflation/device.” In the “Femoral Access” column, the No./total No. (%) was changed to 952/1076 (88.5%) for drug-eluting stents, 113/1076 (10.5%) for bare metal stents, and 11/1076 (1.0%) for both, and the median (interquartile range) critical time interval was changed to 185 (132-301) minutes for “Symptom onset to first balloon inflation/device” and 46 (34-61) minutes for “Arrival at PCI center to first balloon inflation/device.” Finally, the P value for table footnote c in Table 2 should be changed to P = .003. This article has been corrected online. This article was previously corrected to fix an incorrect degree for the second author in the byline.

References
1.
Le May  M, Wells  G, So  D,  et al.  Safety and efficacy of femoral access vs radial access in ST-segment elevation myocardial infarction: the SAFARI-STEMI randomized clinical trial.   JAMA Cardiol. 2020;5(2):126-134. doi:10.1001/jamacardio.2019.4852PubMedGoogle ScholarCrossref
×